Epidemiology of diabetic foot and management of foot problems in India
- PMID: 20705622
- DOI: 10.1177/1534734610380026
Epidemiology of diabetic foot and management of foot problems in India
Abstract
Diabetes the global epidemic is rapidly increasing at an alarming rate. Developing countries like India harbor the majority of diabetic people and by the year 2030 AD India will have the largest number of diabetic patients. Diabetic foot is one of the common diabetic complications found in India. Both aerobic and anaerobic pathogens form the etiology for diabetic foot infection. Members of the Enterobacteriaceae family were the most prominent among the aerobes while members of the Genus Peptostreptococcus and Clostridium were most prominent among the anaerobes. Ulcers infected with anaerobic pathogens showed a longer healing time than ulcers infected with aerobic pathogens. Oxidative stress is one of the major markers of inflammatory response and oxidative stress markers such as lipid peroxidation, thiobarbituric acid reactive substance (TBARS), Superoxide Dismutase (SOD), Catalase, G Peroxidase, G-S Peroxidase and plasma total antioxidant play a major role in the nonhealing of diabetic foot ulcers. Growth factors such as platelet-derived growth factor (PDGF), transforming growth factor (VEGF), and epidermal growth factor (EGF) are needed for normal wound repair, while proteases such as matrix metalloproteinase (MMP) and serine proteases found in chronic wounds delay the healing process.
Similar articles
-
Prevalence of pathogens in diabetic foot infection in South Indian type 2 diabetic patients.J Assoc Physicians India. 2002 Aug;50:1013-6. J Assoc Physicians India. 2002. PMID: 12421021
-
Managing diabetic foot infection in India.Int J Low Extrem Wounds. 2013 Jun;12(2):158-66. doi: 10.1177/1534734613486153. Epub 2013 May 9. Int J Low Extrem Wounds. 2013. PMID: 23667101 Review.
-
Oxidative stress markers regulating the healing of foot ulcers in patients with type 2 diabetes.Wounds. 2009 Oct;21(10):273-9. Wounds. 2009. PMID: 25902714
-
An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers.Adv Skin Wound Care. 2008 Dec;21(12):568-75. doi: 10.1097/01.ASW.0000323589.27605.71. Adv Skin Wound Care. 2008. PMID: 19065083
-
Protocol for treatment of diabetic foot ulcers.Am J Surg. 2004 May;187(5A):1S-10S. doi: 10.1016/S0002-9610(03)00299-X. Am J Surg. 2004. PMID: 15147985 Review.
Cited by
-
Antimicrobial susceptibility pattern in diabetic foot ulcer: a pilot study.Ann Med Health Sci Res. 2014 Sep;4(5):742-5. doi: 10.4103/2141-9248.141541. Ann Med Health Sci Res. 2014. PMID: 25328786 Free PMC article.
-
Choices and Challenges of Antibiotics Therapy in Diabetic Foot Infection.Indian J Endocrinol Metab. 2017 Sep-Oct;21(5):647-648. doi: 10.4103/ijem.IJEM_481_17. Indian J Endocrinol Metab. 2017. PMID: 28989866 Free PMC article. No abstract available.
-
Development and validation of an interprofessional collaborative educational module on the self-management of foot for individuals with type II diabetes mellitus in India.F1000Res. 2025 Feb 4;13:386. doi: 10.12688/f1000research.146943.4. eCollection 2024. F1000Res. 2025. PMID: 40655936 Free PMC article.
-
Diabetes mellitus and its complications in India.Nat Rev Endocrinol. 2016 Jun;12(6):357-70. doi: 10.1038/nrendo.2016.53. Epub 2016 Apr 15. Nat Rev Endocrinol. 2016. PMID: 27080137 Review.
-
Combined metabolomics and network pharmacology to elucidate the mechanisms of Dracorhodin Perchlorate in treating diabetic foot ulcer rats.Front Pharmacol. 2022 Nov 18;13:1038656. doi: 10.3389/fphar.2022.1038656. eCollection 2022. Front Pharmacol. 2022. PMID: 36532755 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical